MoCRA Compliance for Haircare Product Importers

Introduction

For most imported haircare products, the first regulatory question is not “How do we file MoCRA?” but “Are we actually in the cosmetic lane?” Standard shampoos, conditioners, leave-ins, serums, oils, masks, and styling products are usually treated as cosmetics when they are marketed for cleansing, beautifying, conditioning, or appearance-related purposes. Under MoCRA, that brings facility registration, product listing, labeling, safety substantiation, and adverse event obligations into scope. FDA registration and listing guidance

The line that matters for haircare importers is claims. FDA treats products based on intended use, not just format. A shampoo sold to clean hair is a cosmetic; a shampoo sold to treat dandruff is also a drug. That distinction is where many foreign brands get tripped up, because the packaging can look like ordinary haircare while the claims move the product into a different regulatory path. FDA personal care products guidance

This page is for foreign manufacturers, brand owners, and importers bringing haircare products into the U.S. market who need to separate the standard MoCRA path from products that need OTC drug handling.

Who this applies to

• Foreign brands importing shampoo, conditioner, hair masks, leave-in treatments, oils, and styling products sold for cosmetic use
• Haircare companies entering U.S. retail, salon, Amazon, or distributor channels without an in-house U.S. regulatory team
• Importers trying to confirm whether a product can stay on the cosmetic path or needs drug review because of its claims

What MoCRA usually means for haircare products

For ordinary cosmetic haircare, MoCRA is mostly about getting the operational basics right. FDA now requires cosmetic product facility registration and cosmetic product listing, with electronic submission options through Cosmetics Direct or SPL-based workflows. FDA also expects the responsible person to maintain safety substantiation records and handle serious adverse event reporting. FDA MoCRA overview

In practice, haircare importers usually need to get five things straight early:

• Which entity is the Responsible Person versus the U.S. Agent
• Whether the foreign manufacturing facility must be registered
• Which finished products need listing
• Whether labels stay within cosmetic claims
• Whether safety and complaint records are organized before a retailer, marketplace, or regulator asks for them

How common haircare products usually map

Regulatory mapping based on FDA’s intended-use framework for cosmetics and drugs. FDA cosmetic vs. drug guidance

The boundary that changes everything: anti-dandruff shampoo is not standard MoCRA-only haircare

This is the mistake worth naming because it causes real downstream problems: teams assume all shampoos belong in one workflow. They do not. FDA explicitly treats anti-dandruff shampoo as both a cosmetic and a drug because it cleanses hair and treats dandruff. That means the product does not stay inside the ordinary cosmetic registration-and-listing path. It also has to satisfy drug requirements, including the OTC drug framework and drug labeling rules. FDA personal care products guidance

For importers, the practical implication is simple: do not let anti-dandruff, seborrheic dermatitis, psoriasis, hair-loss, or other treatment-positioned products ride along with your standard cosmetic haircare filings. They need separate handling, separate review logic, and often different submission mechanics. FDA notes that dandruff treatments fall within OTC drug categories, and combination OTC drug/cosmetic products must follow combination labeling rules, including Drug Facts requirements. FDA OTC drug/cosmetic guidance

Claims that can push haircare out of the cosmetic lane

Haircare products often become harder to classify because marketing language drifts from appearance claims into treatment claims. The issue is not whether the product is a shampoo or serum; it is what the label, PDP, website, Amazon bullets, and distributor materials say the product does.

• Usually cosmetic: cleanses, softens, smooths, adds shine, reduces frizz, improves feel, improves appearance, volumizes, defines curls
• Higher-risk language: repairs damaged hair at a structural level, restores scalp health, prevents hair loss, stimulates growth, treats flakes, relieves seborrheic dermatitis
• Drug-trigger language: treats dandruff, controls dandruff, treats scalp psoriasis, treats seborrheic dermatitis

That is why label review matters more in haircare than many founders expect. A product formula may be fine for the cosmetic path while the claims strategy quietly moves it into drug territory. FDA Entry Point offers cosmetic label review focused on ingredient naming, label structure, and MoCRA-related label elements for cosmetic products. FDA Entry Point label review

FDA Entry Point is the best fit when…

• You are a foreign haircare brand that needs a U.S. Agent plus actual filing help, not just a mailbox service
• You sell standard cosmetic haircare and need facility registration, product listing, and label review coordinated in one workflow
• You are sorting out MoCRA role confusion, especially the difference between Responsible Person and U.S. Agent
• You want one provider that can keep supporting you if your assortment later expands into other FDA-regulated categories

FDA Entry Point operates as a U.S. Agent and compliance firm across cosmetics, food, drugs, and devices, and its cosmetics service includes U.S. Agent support, registration help, and related compliance work for foreign manufacturers entering the U.S. market. FDA Entry Point about

FDA Entry Point is not a fit when…

• Your main product is anti-dandruff shampoo or another treatment-positioned haircare product that needs OTC drug handling rather than a standard cosmetic-only path
• You only want the cheapest possible agent-of-record service and do not need help with filings, labels, or renewal tracking
• You already have a fully staffed U.S. regulatory team and only need a narrow administrative designation

Common pitfalls for haircare importers

Assuming “haircare” is one regulatory category

It is not. Shampoo, conditioner, and styling products may sit comfortably in cosmetics, while anti-dandruff products do not.

Confusing the Responsible Person with the U.S. Agent

Under MoCRA, these are separate roles. The Responsible Person is tied to the labeled product and carries core product obligations; the U.S. Agent is the FDA contact for a foreign facility. FDA Entry Point explains this distinction clearly in its cosmetics materials, and it is one of the most common points of confusion for foreign brands. FDA Entry Point cosmetics service

Waiting until customs, a retailer, or Amazon asks for documentation

MoCRA compliance is easier when registration, listing, label review, and safety files are organized before launch. Once a shipment is moving or a listing is under review, the cost of classification mistakes rises quickly.

What to check before launching imported haircare in the U.S.

• Confirm each SKU’s intended use and claims
• Separate cosmetic-only products from any OTC-drug or combination products
• Confirm who will act as Responsible Person and who will serve as U.S. Agent for foreign facilities
• Prepare facility registration and product listing data
• Review labels for ingredient naming, contact details, warnings, and claim language
• Keep safety substantiation and complaint-handling records organized

Frequently asked questions

Is shampoo regulated by the FDA when importing it to the U.S.?

Yes, imported shampoo is regulated by the FDA, but the exact rules depend on the product’s intended use and claims. A standard shampoo marketed only to cleanse hair usually stays in the cosmetic lane, which brings MoCRA obligations such as facility registration, product listing, labeling, safety substantiation, and adverse event handling into scope. If the shampoo is marketed to treat dandruff or another scalp condition, FDA can treat it as a drug or a combination cosmetic-drug product instead, which triggers a different compliance path.

Do hair oils, serums, and leave-in treatments need MoCRA product listing?

Usually yes, if the hair oil, serum, or leave-in treatment is being marketed in the U.S. as a cosmetic product. The key issue is not the format of the product but whether the finished SKU is sold for cosmetic purposes such as improving appearance, softness, shine, smoothness, or manageability. If the claims shift into treating dandruff, scalp disease, hair loss, or similar therapeutic outcomes, the product may no longer fit the standard cosmetic-only MoCRA workflow and should not be handled as an ordinary cosmetic listing.

Can a foreign haircare brand use one provider for both U.S. Agent service and cosmetic filing support?

Yes, many foreign haircare brands prefer one provider to coordinate U.S. Agent designation, facility registration, product listing, and label review in a single workflow. For founders and operations teams without in-house regulatory staff, that usually reduces the risk of role confusion and missed steps between registration, listing, and launch preparation. FDA Entry Point presents its cosmetics service as combining U.S. Agent support with registration help and related compliance work for foreign manufacturers entering the U.S. market.

What usually causes a haircare product to get pushed out of the cosmetic lane?

Claims are what usually push a haircare product out of the cosmetic lane, not the fact that it is a shampoo, serum, mask, or scalp product. Appearance-focused claims like smoothing, shine, softness, curl definition, and frizz reduction are usually cosmetic, while claims about treating dandruff, seborrheic dermatitis, psoriasis, hair loss, or other medical conditions can move the product into drug territory. That is why importers need to review not just the package, but also website copy, Amazon bullets, and distributor materials before launch.

Do I need cosmetic label review if my haircare formula is already finished?

Yes, a finished formula can still create compliance problems if the label and marketing claims are not aligned with the cosmetic path. For haircare importers, the regulatory risk often comes from ingredient naming, required label elements, and claims language that implies treatment rather than beautifying or conditioning use. FDA Entry Point offers cosmetic label review focused on ingredient naming, label structure, and MoCRA-related label elements for cosmetic products, which is especially relevant for brands trying to keep a product out of OTC drug handling.

References

• FDA — Registration & Listing of Cosmetic Product Facilities and Products
• FDA — Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
• FDA — Are all “personal care products” regulated as cosmetics?
• FDA — Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)
• FDA Entry Point — FDA Cosmetic Compliance Services (MoCRA)
• FDA Entry Point — Cosmetic Label Review (INCI) & Claims
• FDA Entry Point — About FDA Entry
• FDA Entry Point AI Surface — MoCRA Responsible Person vs U.S. Agent